C-fiber activation
Showing 1 - 25 of >10,000
Pain Perception, Secondary Hyperalgesia Trial in Basel (Study Intervention: 25 ms half-sine wave stimulation, Control
Recruiting
- Pain Perception
- Secondary Hyperalgesia
- Study Intervention: 25 ms half-sine wave stimulation
- Control Intervention: 500 µs rectangular shaped stimulation
-
Basel, SwitzerlandDepartment of Anaesthesiology, University Hospital of Basel (USB
Jun 28, 2022
Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)
Not yet recruiting
- Alzheimer Disease
- [11C]-UCB-J
- +3 more
-
Lille, France
- +2 more
Jun 12, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Postprandial Glycemic Response Trial in Toronto (SFF, Glucose, SFF chocolate chips)
Completed
- Postprandial Glycemic Response
- SFF
- +3 more
-
Toronto, Ontario, CanadaINQUIS Clinical Research, Ltd
Oct 17, 2022
Microglial Activation inMS Patient Cohort at Risk of Progression
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
Diabetes, Gastroparesis With Diabetes Trial in Rochester (PET/CT Scan with 11C-ER176, Core biopsy of gastric muscle)
Active, not recruiting
- Diabetes
- Gastroparesis With Diabetes Mellitus
- PET/CT Scan with 11C-ER176
- Core biopsy of gastric muscle
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 11, 2022
Tetralogy of Fallot Trial in Bordeaux (Electrophysiological exploration of the right ventricle)
Not yet recruiting
- Tetralogy of Fallot
- Electrophysiological exploration of the right ventricle
-
Bordeaux, FranceCHU de Bordeaux
Aug 2, 2022
Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)
Recruiting
- Alzheimer Disease
-
New York, New YorkColumbia University Irving Medical Center
Jan 10, 2022
Depression Trial in Montpellier (Efficacy of Behavioral Self-Activation with virtual reality, Efficacy of Behavioral
Recruiting
- Depression
- Efficacy of Behavioral Self-Activation with virtual reality
- Efficacy of Behavioral Self-Activation without virtual reality
-
Montpellier, FranceUniversity Hospital of Montpellier
Dec 24, 2021
Acute Decompensated Heart Failure Trial in Birmingham (Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT)
Withdrawn
- Acute Decompensated Heart Failure
- Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Medical Center
Feb 15, 2022
Multiple Sclerosis Trial in Boston ([F-18]PBR06, [C-11]Methylreboxetine)
Recruiting
- Multiple Sclerosis
-
Boston, MassachusettsPartners MS Center, 60 Fenwood Road
Jul 26, 2021
sCD163 in PBC Patients - Assessment of Treatment Response
Recruiting
- Primary Biliary Cirrhosis
- +2 more
- Blood samples
- +3 more
-
Aarhus C, Region Midtjylland, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
Aug 11, 2022
NET Activation in Congenital Heart Disease and Heart Failure
Not yet recruiting
- Congenital Heart Disease
- +2 more
- Biological markers of myocardial fibrosis
-
Paris, France
- +1 more
Feb 21, 2022
Meta-analysis of Oat Fiber and Cardiovascular Risk Reduction.
Active, not recruiting
- Cardiovascular Diseases
- Coronary Heart Disease
- Oats or Oat Fibre
-
Toronto, Ontario, CanadaThe Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
Dec 9, 2021
Neuropsychiatric Syndromes Trial in Houston (PET with radiotracer [11C]PBR-28 ( or [11C]ER176), Affective challenge)
Recruiting
- Neuropsychiatric Syndromes
- PET with radiotracer [11C]PBR-28 ( or [11C]ER176)
- Affective challenge
-
Houston, TexasBBSB at UTHealth
Sep 27, 2021
Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)
Active, not recruiting
- Low-grade Glioma
- +2 more
-
Calgary, Alberta, Canada
- +6 more
Oct 25, 2022
Small Fiber Neuropathy, Idiopathic Peripheral Neuropathy Trial in Boston (Intravenous immunoglobulin, 0.9% Sodium Chloride)
Active, not recruiting
- Small Fiber Neuropathy
- Idiopathic Peripheral Neuropathy
- Intravenous immunoglobulin
- 0.9% Sodium Chloride
-
Boston, MassachusettsBeth Israel Deaconness Medical Center
Apr 16, 2021
Complement Activation in the Lysosomal Storage Disorders
Withdrawn
- Fabry Disease
- +3 more
- Complement measurements
-
Melbourne, Victoria, AustraliaThe Royal Melbourne Hospital
Jun 2, 2021
Alzheimer Trial in New York (11C-ER176, 18F-MK6240, 18F-Florbetaben)
Recruiting
- Alzheimer Disease
- 11C-ER176
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Jul 28, 2021
Satiety of High Fiber High Protein Bread Trial in Toronto (EverVita Pro, Control bread)
Completed
- Satiety of High Fiber High Protein Bread
- EverVita Pro
- Control bread
-
Toronto, Ontario, CanadaINQUIS Clinical Research
Jul 26, 2022
CBD, Healthy Trial in New Haven ([11C]PBR28, Low-dose lipopolysaccharide, Intradermal Capsaicin)
Recruiting
- CBD
- Healthy
- [11C]PBR28
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 3, 2021
Lymphoma, Lung Cancer, Colo-rectal Cancer Trial in Barrie, Hamilton, Toronto (SMARTCare, Control)
Terminated
- Lymphoma
- +2 more
- SMARTCare
- Control
-
Barrie, Ontario, Canada
- +2 more
Sep 29, 2021
Multiple Sclerosis, Alzheimer's Disease Trial in Boston ([F-18]PBR06, [C-11]PBR28)
Recruiting
- Multiple Sclerosis
- Alzheimer's Disease
-
Boston, MassachusettsPartners MS Center, 60 Fenwood Road
Dec 9, 2020
Chronic Low-back Pain Trial (lumbar spinal manipulative therapy, sham spinal manipulative therapy, full spine spinal
Not yet recruiting
- Chronic Low-back Pain
- lumbar spinal manipulative therapy
- +2 more
- (no location specified)
Aug 2, 2023